ARSA QC DBS Service
Quality Control for Newborn Screening Labs
Applied/ServiceActive
Key Facts
About Enfanos
Enfanos is a private, early-stage biotech firm leveraging proprietary mass spectrometry-based platforms to create reagents and methods for enzyme activity assays, with a strong focus on lysosomal storage disorders and newborn screening research. Originating from the renowned Gelb laboratory at the University of Washington, the company commercializes over two decades of academic innovation. Its business model is primarily service and product-based, providing essential tools to research and diagnostic labs. While currently in a pre-revenue or early-revenue stage, Enfanos has established a key partnership with Waters Corporation to advance its technology applications.
View full company profile